By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation

• Conditions: Hepatocellular Carcinoma

• Registration Number: NCT03880721
• Lead Sponsor: Chinese PLA General Hospital

Brief Summary

Developing a radiomics model to predict the prognosis of patients with hepatocellular carcinoma after microwave ablation to provide advice for their treatment.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-01-01
• Study First Submitted: 2019-03-17
• Study First Submitted QC: 2019-03-17
• Study First Posted: 2019-03-19
• Status Verified: 2019-05
• Last Update Submitted: 2019-05-22
• Last Update Posted: 2019-05-24
• Primary Completion: 2020-08
• Study Completion: 2021-04

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Patients with primary hepatocellular carcinoma in the department of interventional ultrasound, PLA general hospital, who accept MWA therapy for HCC

Inclusion criteria:

1. Primary hepatocellular
2. No other treatments ware performed before microwave ablation
3. Patient has been clinically diagnosed with HCC definitely, and have a definite operational indication
4. No extrahepatic manifestations and no evidence of vessel invasion and bile duct thrombi

Exclusion Criteria

• Exclusion criteria:

  1. Non-primary hepatocellular carcinoma or hepatic metastases
  2. Accept other treatment before microwave ablation
  3. Extrahepatic metastasis, vessel invasion or bile duct thrombi

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Specificity	through study completion, an average of 2 year	diagnosis specificity of intelligent ultrasound analysis
Sensitivity	through study completion, an average of 2 year	diagnosis sensitivity of intelligent ultrasound analysis
AUC value	through study completion, an average of 2 year	Utilizing area under curve to judge the accurency

Trial Locations

Locations (1)

Chinese PLA General Hospital; 🇨🇳 Beijing, Beijing, China